Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2015 3
2016 6
2017 6
2018 1
2019 3
2020 6
2021 7
2022 5
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Results by year
Filters applied: . Clear all
Page 1
The Subway.
Awdish R. Awdish R. Chest. 2021 Jan;159(1):435-436. doi: 10.1016/j.chest.2020.10.037. Epub 2020 Oct 22. Chest. 2021. PMID: 33132089 No abstract available.
[No title available]
Awdish R. Awdish R. Chest. 2020 Oct 22:S0012-3692(20)34932-1. doi: 10.1016/j.chest.2020.10.037. Online ahead of print. Chest. 2020. PMID: 34756835 No abstract available.
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.
White RJ, Jerjes-Sanchez C, Bohns Meyer GM, Pulido T, Sepulveda P, Wang KY, Grünig E, Hiremath S, Yu Z, Gangcheng Z, Yip WLJ, Zhang S, Khan A, Deng CQ, Grover R, Tapson VF; FREEDOM-EV Investigators. White RJ, et al. Am J Respir Crit Care Med. 2020 Mar 15;201(6):707-717. doi: 10.1164/rccm.201908-1640OC. Am J Respir Crit Care Med. 2020. PMID: 31765604 Free PMC article. Clinical Trial.
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Hoeper MM, Al-Hiti H, Benza RL, Chang SA, Corris PA, Gibbs JSR, Grünig E, Jansa P, Klinger JR, Langleben D, McLaughlin VV, Meyer GMB, Ota-Arakaki J, Peacock AJ, Pulido T, Rosenkranz S, Vizza CD, Vonk-Noordegraaf A, White RJ, Chang M, Kleinjung F, Meier C, Paraschin K, Ghofrani HA, Simonneau G; REPLACE investigators. Hoeper MM, et al. Lancet Respir Med. 2021 Jun;9(6):573-584. doi: 10.1016/S2213-2600(20)30532-4. Epub 2021 Mar 24. Lancet Respir Med. 2021. PMID: 33773120 Clinical Trial.
Artist's Statement: Sanitized.
Awdish R. Awdish R. Acad Med. 2022 Sep 1;97(9):1317. doi: 10.1097/ACM.0000000000004791. Epub 2022 Aug 26. Acad Med. 2022. PMID: 36098779 No abstract available.
Restoration in the Aftermath.
Awdish RLA. Awdish RLA. Ann Am Thorac Soc. 2022 Oct;19(10):1631-1633. doi: 10.1513/AnnalsATS.202205-427IP. Ann Am Thorac Soc. 2022. PMID: 35687488 Free PMC article. No abstract available.
The Liminal Space.
Awdish RLA. Awdish RLA. N Engl J Med. 2020 Jul 23;383(4):e17. doi: 10.1056/NEJMp2012147. Epub 2020 Jun 3. N Engl J Med. 2020. PMID: 32492299 No abstract available.
Serious illness conversations in pulmonary hypertension.
Ismail R, Hegab S, Kelly B, Franco-Palacios DJ, Grafton G, Smith ZR, Awdish RLA. Ismail R, et al. Pulm Circ. 2021 Oct 27;11(4):20458940211037529. doi: 10.1177/20458940211037529. eCollection 2021 Oct-Dec. Pulm Circ. 2021. PMID: 34733492 Free PMC article. Review.
37 results